NO328949B1 - Endoparasittiske sammensetninger, fremgangsmate for fremstilling derav samt anvendelse av cyklodepsipeptid - Google Patents

Endoparasittiske sammensetninger, fremgangsmate for fremstilling derav samt anvendelse av cyklodepsipeptid Download PDF

Info

Publication number
NO328949B1
NO328949B1 NO20023976A NO20023976A NO328949B1 NO 328949 B1 NO328949 B1 NO 328949B1 NO 20023976 A NO20023976 A NO 20023976A NO 20023976 A NO20023976 A NO 20023976A NO 328949 B1 NO328949 B1 NO 328949B1
Authority
NO
Norway
Prior art keywords
spp
compositions
compositions according
cyclodepsipeptide
weight
Prior art date
Application number
NO20023976A
Other languages
English (en)
Norwegian (no)
Other versions
NO20023976L (no
NO20023976D0 (no
Inventor
Norbert Mencke
Achim Harder
Georg Von Samson-Himmelstjerna
Michael Traubel
Michael Stegemann
Jochen Kalbe
Original Assignee
Bayer Animal Health Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Animal Health Gmbh filed Critical Bayer Animal Health Gmbh
Publication of NO20023976D0 publication Critical patent/NO20023976D0/no
Publication of NO20023976L publication Critical patent/NO20023976L/no
Publication of NO328949B1 publication Critical patent/NO328949B1/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/15Depsipeptides; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017Non-human animal skin, e.g. pour-on, spot-on
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO20023976A 2000-02-22 2002-08-21 Endoparasittiske sammensetninger, fremgangsmate for fremstilling derav samt anvendelse av cyklodepsipeptid NO328949B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10008128A DE10008128A1 (de) 2000-02-22 2000-02-22 Endoparasitizide Mittel
PCT/EP2001/001392 WO2001062268A1 (de) 2000-02-22 2001-02-09 Endoparasitizide mittel

Publications (3)

Publication Number Publication Date
NO20023976D0 NO20023976D0 (no) 2002-08-21
NO20023976L NO20023976L (no) 2002-10-21
NO328949B1 true NO328949B1 (no) 2010-06-28

Family

ID=7631886

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20023976A NO328949B1 (no) 2000-02-22 2002-08-21 Endoparasittiske sammensetninger, fremgangsmate for fremstilling derav samt anvendelse av cyklodepsipeptid

Country Status (25)

Country Link
US (1) US20030125244A1 (es)
EP (1) EP1259250B1 (es)
JP (2) JP5596249B2 (es)
KR (1) KR100755414B1 (es)
CN (1) CN1309415C (es)
AR (2) AR028218A1 (es)
AT (1) ATE343394T1 (es)
AU (2) AU2001240605B2 (es)
BR (1) BR0108562B1 (es)
CA (1) CA2400610C (es)
CZ (1) CZ300242B6 (es)
DE (2) DE10008128A1 (es)
DK (1) DK1259250T3 (es)
ES (1) ES2274871T3 (es)
HK (1) HK1054326B (es)
HU (1) HUP0204554A3 (es)
IL (2) IL150988A0 (es)
MX (1) MXPA02008210A (es)
NO (1) NO328949B1 (es)
NZ (1) NZ520856A (es)
PL (1) PL203999B1 (es)
PT (1) PT1259250E (es)
RU (1) RU2292905C2 (es)
WO (1) WO2001062268A1 (es)
ZA (1) ZA200205982B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10104362A1 (de) * 2001-02-01 2002-08-08 Bayer Ag Kristallmodifikation eines cyclischen Depsipeptids mit besserer Wirksamkeit
JP4176077B2 (ja) * 2002-11-12 2008-11-05 社団法人北里研究所 新規fki−1033物質およびその製造法
DE10358525A1 (de) * 2003-12-13 2005-07-07 Bayer Healthcare Ag Endoparasitizide Mittel zur topischen Applikation
DE102005011779A1 (de) * 2005-03-11 2006-09-14 Bayer Healthcare Ag Endoparasitizide Mittel
EP2334687B9 (en) 2008-08-28 2012-08-08 Pfizer Inc. Dioxa-bicyclo[3.2.1.]octane-2,3,4-triol derivatives
DE102009012423A1 (de) 2009-03-10 2010-09-16 Bayer Animal Health Gmbh Zubereitung auf Ölbasis
JP7045191B2 (ja) * 2015-05-20 2022-03-31 ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド 駆虫性デプシペプチド化合物
RU2020107484A (ru) 2015-12-28 2020-03-19 Мериал, Инк. Противогельминтные депсипептидные соединения
WO2018093920A1 (en) 2016-11-16 2018-05-24 Merial, Inc. Anthelmintic depsipeptide compounds
WO2021028479A1 (en) 2019-08-14 2021-02-18 Vetoquinol S.A. Compositions comprising tigolaner for controlling parasites

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3531545A1 (de) * 1985-09-04 1987-03-05 Goedecke Ag Arzneimittel mit einem gehalt an calcium-antagonisten und deren verwendung
DE3705227A1 (de) * 1987-02-19 1988-09-01 Bayer Ag Anthelminthische wirkstoffkombinationen
JP2874342B2 (ja) * 1992-03-17 1999-03-24 藤沢薬品工業株式会社 デプシペプチド誘導体,その製法およびその用途
DE4317458A1 (de) * 1992-06-11 1993-12-16 Bayer Ag Verwendung von cyclischen Depsipeptiden mit 18 Ringatomen zur Bekämpfung von Endoparasiten, neue cyclische Depsipeptide mit 18 Ringatomen und Verfahren zu ihrer Herstellung
DE4309830C1 (de) * 1993-03-26 1994-05-05 Lohmann Therapie Syst Lts Wirkstoffpflaster für die Abgabe von Estradiol an die Haut
DE4317457A1 (de) * 1993-05-26 1994-12-01 Bayer Ag Octacyclodepsipeptide mit endoparasitizider Wirkung
DE4317432A1 (de) * 1993-05-26 1994-12-01 Bayer Ag Octacyclodepsipeptide mit endoparasitizider Wirkung
DE4400464A1 (de) * 1994-01-11 1995-07-13 Bayer Ag Endoparasitizide Mittel
WO1995021624A1 (fr) * 1994-02-08 1995-08-17 Nippon Kayaku Kabushiki Kaisha Preparation sous forme de solution a base d'une forte concentration d'aureobasidine
DE4417742A1 (de) * 1994-05-20 1995-11-23 Bayer Ag Nicht-systemische Bekämpfung von Parasiten
DE19520275A1 (de) * 1995-06-02 1996-12-05 Bayer Ag Endoparasitizide Mittel
DE19545044A1 (de) * 1995-12-02 1997-06-05 Bayer Ag Endoparasitizide Mittel
GB9803448D0 (en) * 1998-02-18 1998-04-15 Pharma Mar Sa Pharmaceutical formulation
DE69925255T2 (de) * 1998-03-19 2006-02-23 Merck & Co., Inc. Schwefelpentafluorophenylpyrazole zur kontrolle von ektoparasitenbefall
FR2776191B1 (fr) * 1998-03-23 2002-05-31 Theramex Composition hormonale topique a effet systemique
DE19921887A1 (de) * 1999-05-12 2000-11-16 Bayer Ag Endoparasitizide Mittel

Also Published As

Publication number Publication date
RU2002125493A (ru) 2004-03-20
CN1404397A (zh) 2003-03-19
NO20023976L (no) 2002-10-21
ATE343394T1 (de) 2006-11-15
HK1054326A1 (en) 2003-11-28
MXPA02008210A (es) 2003-01-28
IL150988A0 (en) 2003-02-12
HK1054326B (zh) 2007-11-09
WO2001062268A1 (de) 2001-08-30
RU2292905C2 (ru) 2007-02-10
PL357551A1 (en) 2004-07-26
HUP0204554A3 (en) 2005-05-30
PL203999B1 (pl) 2009-11-30
KR20020072577A (ko) 2002-09-16
JP2012107024A (ja) 2012-06-07
IL150988A (en) 2011-06-30
NO20023976D0 (no) 2002-08-21
PT1259250E (pt) 2007-01-31
BR0108562A (pt) 2002-11-12
CZ300242B6 (cs) 2009-03-25
DK1259250T3 (da) 2007-02-26
CA2400610A1 (en) 2001-08-30
DE10008128A1 (de) 2001-08-23
CN1309415C (zh) 2007-04-11
BR0108562B1 (pt) 2013-03-05
KR100755414B1 (ko) 2007-09-04
AR085989A2 (es) 2013-11-13
AU2001240605B2 (en) 2005-04-21
CZ20022867A3 (cs) 2003-01-15
NZ520856A (en) 2005-04-29
ZA200205982B (en) 2003-07-28
HUP0204554A2 (en) 2003-05-28
ES2274871T3 (es) 2007-06-01
EP1259250A1 (de) 2002-11-27
JP2003523397A (ja) 2003-08-05
US20030125244A1 (en) 2003-07-03
AR028218A1 (es) 2003-04-30
DE50111315D1 (de) 2006-12-07
CA2400610C (en) 2013-01-22
AU4060501A (en) 2001-09-03
EP1259250B1 (de) 2006-10-25
JP5596249B2 (ja) 2014-09-24

Similar Documents

Publication Publication Date Title
US7763583B2 (en) Endoparasiticidal compositions for topical application
CA2600638C (en) Composition comprising emodepside and praziquantel or epsiprantel
ES2274871T3 (es) Agentes endoparaciticidas.

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: BAYER INTELLECTUAL PROPERTY GMBH, DE

MK1K Patent expired